Pathkey.ai Limited has released a press release.
TrialKeys AI Predictions Continue to Outperform
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Pathkey.AI
- Pathkey Advances TrialKey with Drug-Level AI Features
- Successful TrialKey Observational Predictions
- Preliminary Financial Report - 30 June 2025
- Opyl Signs Service Agreement with Innovatrix
- Treasury Update
Later from Pathkey.AI
- Pathkey.AI and Armstrong Clinical Partner on AI Trials
- Trading Halt
- PKY Completes $2.5m Placement and Launches Rights Issue
- Offer Document
- Quarterly Activities & Cashflow Report
Follow Pathkey.AI into a list and get an email when it puts out news.
Follow Pathkey.AI